⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Krzysztof JakubowskiMD

Internal Medicine · Meriden, CT 6451

NPI: 1013978691

Share:𝕏fin

15

🟡 Moderate

🤖 ML Fraud Detection Score: 87%

Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.

Learn more →

Risk Flags

Elevated antipsychotic prescribing (65+)Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

17,901

Total Claims

$2.2M

Drug Cost

951

Beneficiaries

$2,334

Cost/Patient

Risk Score Breakdown 15/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8
Elderly antipsychotic prescribing+5

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

+128%

Opioid rate vs peers

5.1% vs 2.2% avg

+65%

Cost per patient vs peers

$2,334 vs $1,411 avg

+14%

Brand preference vs peers

12.2% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

Opioid Prescribing

5.1%

Opioid Rate

913

Opioid Claims

$154K

Opioid Cost

8.1%

Long-Acting Rate

Brand vs Generic

88% generic

Brand: 2,154 claims · $1.8M

Generic: 15,551 claims · $408K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Apixaban162$178K
Sitagliptin Phosphate117$164K
Dapagliflozin Propanediol105$152K
Linagliptin77$79K
Semaglutide46$77K
Insulin Degludec38$67K
Rivaroxaban38$64K
Fluticasone/Umeclidin/Vilanter54$59K
Empagliflozin50$55K
Oxycodone Hcl32$54K
Umeclidinium Brm/Vilanterol Tr47$53K
Insulin Glargine,hum.Rec.Anlog42$48K
Fluticasone/Vilanterol79$44K
Dulaglutide29$40K
Insulin Degludec25$39K

Prescribing Profile

182

Unique Drugs

$635K

IRA Negotiated Drugs

$140K

GLP-1 Drugs

15.0

Anomaly Score

Patient Profile

75

Avg Age

52%

Female

1.05

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About